1. E2F1 Reduces Sorafenib’s Sensitivity of Esophageal Carcinoma Cells via Modulating the miR-29c-3p/COL11A1 Signaling Axis
   Zhifeng Ma et al, 2023, Current Molecular Pharmacology CrossRef
2. Integration of TE Induces Cancer Specific Alternative Splicing Events
   Woo Ryung Kim et al, 2022, International Journal of Molecular Sciences CrossRef
3. A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients
   Devis Pascut et al, 2019, Scientific Reports CrossRef
4. DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-κB signaling pathway by targeting TRAF1 in hepatocellular carcinoma
   Bin Zhu et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
5. Molecular mechanism for metformin to enhance pro-apoptotic effect of sorafenib in HepG2 cells
   Yan-Qing Ye et al, 2020, World Chinese Journal of Digestology CrossRef
6. MiR-378a-3p Acts as a Tumor Suppressor in Colorectal Cancer Stem-Like Cells and Affects the Expression of MALAT1 and NEAT1 lncRNAs
   Giorgia Castellani et al, 2022, Frontiers in Oncology CrossRef
7. MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
   Behnaz Lahooti et al, 2021, Frontiers in Oncology CrossRef
8. The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy
   Yin-Xiang Ren et al, 2022, Journal of Oncology CrossRef
9. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma
   Mohamed H. Yousef et al, 2020, BioMed Research International CrossRef